Alnylam Pharmaceuticals | ALNY - Lucro Operacional

Preço das Ações
312.05
Mudança Diária
0.95 0.31%
Mensal
-5.25%
Anual
10.13%
Q1 Previsão
303.95




Lucro Operacional Alterar Data
Acadia Pharmaceuticals USD 17.39M 18.36M 2025-12
Agios Pharmaceuticals USD -121.58M 4.71M 2025-12
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
Amgen USD 3.96B 464M 2025-12
Arrowhead Research USD 40.81M 3.3M 2025-12
BioCryst Pharmaceuticals USD 260.38M 230.79M 2025-12
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Incyte USD 383.88M 47.43M 2025-12
Ionis Pharmaceuticals USD -215M 54.82M 2025-12
Moderna USD -857M 597M 2025-12
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Novartis USD 4.06B 521M 2025-12
PTC Therapeutics USD -81.62M 85.11M 2025-12
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Sanofi EUR 1.5B 2.29B 2025-12
Sarepta Therapeutics USD -410.08M 347.2M 2025-12
Takeda JPY 168.82B 479.89B 2025-12
Tectonic Therapeutic USD -21.52M 374K 2025-12
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12
Xencor USD -53.63M 6.11M 2025-12